Cardiology

Lasting benefit for CABG in diabetes, multivessel disease

(HealthDay)—For patients with diabetes mellitus (DM) with multivessel coronary disease (MVD), coronary revascularization with coronary artery bypass grafting (CABG) is associated with lower all-cause mortality than percutaneous ...

Cardiology

PCI, CABG both acceptable for CKD patients with LMCAD

(HealthDay)—For patients with left main coronary artery disease (LMCAD), those with and without chronic kidney disease (CKD) undergoing revascularization have similar long-term outcomes with percutaneous coronary intervention ...

Cardiology

CABG may be better than PCI for 3-vessel Dz in younger adults

(HealthDay)—For young patients (≤50 years) with three-vessel coronary artery disease, percutaneous coronary intervention (PCI) is associated with increased rates of adverse outcomes compared with coronary artery bypass ...

Cardiology

Incomplete revascularization in PCI linked to higher mortality

(HealthDay)—The risk of mortality is increased for certain patients undergoing percutaneous coronary intervention (PCI) with incomplete revascularization (IR), according to a study published online Dec. 27 in JAMA Cardiology.

Cardiology

CABG may be best method to revascularize in diabetes

(HealthDay)—In patients with diabetes and multivessel coronary artery disease (MV-CAD), coronary artery bypass grafting (CABG) may be the preferred method of revascularization, with lower rates of major adverse cardiac ...

Cardiology

About one in six readmitted post-revascularization for PAD

(HealthDay)—For patients with peripheral arterial disease who are discharged following peripheral arterial revascularization, 17.6 percent have 30-day nonelective readmission, according to a study published online Dec. ...

page 3 from 13